Relmada Therapeutics, Inc. (RLMD)

Our deep-learning model estimates a per-share fair value from quarterly fundamentals, sector trends, and historical valuation patterns.

The AI score is a probability-weighted estimate — useful for comparing relative attractiveness across stocks, not a trading recommendation.

When historical series are available, the chart overlays the model's fair value against the actual stock price by fiscal year.